Close

GlycoMimetics (GLYC) Announces Publication of Positive GMI-1271 Data in Post-Heart Attack Inflammatory Response Reduction

August 16, 2016 9:30 AM EDT Send to a Friend
GlycoMimetics, Inc. (Nasdaq: GLYC) announced the publication of results from a preclinical study that showed its drug candidate GMI-1271 reduced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login